Virax Biolabs (VRAX) announced that it received a notice from Nasdaq, notifying the company that it is not in compliance with the minimum bid for continued listing on the Nasdaq.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRAX: